Ferroelectricity in Dion–Jacobson ABiNb2O7(A = Rb, Cs) compounds

The ferroelectric properties of 2-layer Dion–Jacobson compounds ABiNb2O7 (A = Rb and Cs) were studied. Ferroelectricity and piezoelectricity of CsBiNb2O7 were demonstrated for the first time. The ferroelectric domain structure of Dion–Jacobson compounds were imaged using PFM. The Curie points of RbBiNb2O7 and CsBiNb2O7 are 1098 ± 5 and 1033 ± 5 °C, respectively. The piezoelectric constant of RbBiNb2O7 and CsBiNb2O7 are approximately 5 and 8 pC N−1. Thermal depoling was also studied to confirm the Curie temperature and the stability of the piezoelectricit

Effect of spark plasma sintering on the structure and properties of Ti1-xZrxNiSn half-heusler alloys

XNiSn (X = Ti, Zr and Hf) half-Heusler alloys have promising thermoelectric properties and are attracting enormous interest for use in waste heat recovery. In particular, multiphase behaviour has been linked to reduced lattice thermal conductivities, which enables improved energy conversion efficiencies. This manuscript describes the impact of spark plasma sintering (SPS) on the phase distributions and thermoelectric properties of Ti0.5Zr0.5NiSn based half-Heuslers. Rietveld analysis reveals small changes in composition, while measurement of the Seebeck coefficient and electrical resistivities reveals that all SPS treated samples are electron doped compared to the as-prepared samples. The lattice thermal conductivities fall between 4 W·m−1·K−1 at 350 K and 3 W·m−1·K−1 at 740 K. A maximum ZT = 0.7 at 740 K is observed in a sample with nominal Ti0.5Zr0.5NiSn composition

Mechanical and magnetic properties of spark plasma sintered soft magnetic FeCo alloy reinforced by carbon nanotubes

Different volume fractions (0.5 vol. % to 4.5 vol. %) of CNTs were used to reinforce a binary Fe50Co soft magnetic alloy. The first method for dispersion was involved dry mixing and ball milling of the powder, while the second was included wet mixing in dimethylformamide under ultrasonic agitation, drying and then dry ball milling. The powders were consolidated using spark plasma sintering. Tensile test and SEM analyses were performed to characterize the mechanical properties and the fracture surface of the sintered materials. The best magnetic and mechanical properties were achieved using the first method. A maximum enhancement in tensile strength of around 20% was observed in the 0.5 vol. % CNT composite with improved elongation compared to the monolithic Fe50Co alloy. In addition, the magnetic properties were enhanced by adding CNTs up to 1 vol. %, and an improvement in densification was observed in composites up to 1.5 vol. % CNT with respect to monolithic Fe50Co alloy

Role of synthesis method on microstructure and mechanical properties of graphene/carbon nanotube toughened Al2O3 nanocomposites

Copyright © 2015 Elsevier. NOTICE: this is the author’s version of a work that was accepted for publication in Ceramics International. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Ceramics International (2015), DOI: 10.1016/j.ceramint.2015.04.054The effects of hot-pressing (HP) and spark plasma sintering (SPS) methods on the grain size, microstructural features, and mechanical behaviour of graphene nanoplatelet/carbon nanotubes (GNTs) reinforced Al2O3 nanocomposites were comprehensively studied. Different graphene nanoplatelet to carbon nanotube ratios were selected as the overall reinforcement content of composites prepared using HP and SPS. Highly densified samples (>98%) were obtained at 1650 °C under 40 MPa in Ar atmosphere, with dwell times of 1 h and 10 min for HP and SPS respectively. Both types of sample showed a mixture of inter- and transgranular fracture behaviour. A 50% grain size reduction was observed for samples prepared by HP compared to SPS samples. Both types of samples achieved a high flexural strength and fracture toughness of >400 MPa and 5.5 MPa m1/2, whilst SPS samples peaked at relatively lower GNT contents than those for the HP samples. Based on analyses of the morphology, grain sizes and fracture mode, similar toughening mechanisms for both types of sample were observed, involving the complex characteristics of the combined GNT fillers.University of Exeter - scholarshipEngineering and Physical Sciences Research Council (EPSRC)Sunchon National University, South Korea - BK21+programm

Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised control led trial

Alcohol misuse is highly prevalent among people attending emergency departments, but the effect of intervention by staff working in these departments is unclear. We investigated the effect of screening and referral of patients found to be misusing alcohol while attending an emergency department

Synthesis and properties of graphene and graphene/carbon nanotube-reinforced soft magnetic FeCo alloy composites by spark plasma sintering

The effect of the addition of graphene nanoplatelets (GNP) and graphene nanoplatelet/carbon nanotube (GNT) mixtures on the mechanical and magnetic properties of spark plasma sintered soft magnetic FeCo alloys was studied. Three different volume fractions (0.5, 1 and 2 vol%) of GNPs and GNTs were investigated. Ball milling was used to disperse the GNPs in monolithic FeCo powder, while magnetic stirring and ultrasonic agitation were used to prepare hybrid GNT prior to ball milling. The highest saturation induction (B sat) of 2.39 T was observed in the 1 vol% GNP composite. An increase in the volume fraction of the ordered nanocrystalline structure was found to reduce the coercivity (H c) of the composites. The addition of CNTs to the GNP composite prevented grain growth, leading to grain refinement. An 18 % increase in hardness was observed in the 1 vol% GNP composite as compared to the as-received FeCo alloy. A reduction in tensile strength was observed in all of the composite materials, except for the 0.5 vol% GNT composite, for which a value of 643 MPa was observed. Raman spectroscopy indicated a reduction in the defect density of the GNPs after adding CNTs

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570